Novartis AG
IMMUNOSUPPRESSANT FORMULATION

Abstract:

The present invention concerns a dosage form, preferably for immediate release, comprising siponimod, a moisture-protective-agent and further pharmaceutical excipients and methods for producing said dosage form.